Associated Papers
BCRP/ABCG2 confers anticancer drug resistance without covalent dimerization.
Shigeta J et al.
Cancer Science, 2010
Interaction with the 5D3 monoclonal antibody is regulated by intramolecular rearrangements but not by covalent dimer formation of the human ABCG2 multidrug transporter.
Ozvegy-Laczka C et al.
The Journal of Biological Chemistry, 2008
Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2.
Kage K et al.
Cancer Science, 2005
Select a paper to view details